scholarly journals Pulmonary rehabilitation of patients with coronavirus infection COVID-19, clinical examples

2020 ◽  
Vol 30 (5) ◽  
pp. 715-722
Author(s):  
N. N. Meshcheryakova ◽  
A. S. Belevskiy ◽  
A. V. Kuleshov
Keyword(s):  
Pulmonary Rehabilitation ◽  
Skeletal Muscles ◽  
International Committee ◽  
World Health ◽  
The Novel ◽  
Republic Of China ◽  
Coronavirus Infection ◽  
Novel Coronavirus ◽  
Health Organization ◽  
The City

At the end of 2019, an outbreak of a new coronavirus infection was identified in the People’s Republic of China centerd in the city of Wuhan. The official name COVID-19 (COronaVIrus Disease 2019) was assigned to the infection caused by the novel coronavirus by the World Health Organization on February 11, 2020. The International Committee on Taxonomy of Viruses assigned the name to the causative agent of the infection – SARS-CoV-2 on February 11, 2020. The bilateral pneumonia is currently known to be the most common clinical manifestation of the variant of coronavirus infection. The development of acute respiratory distress syndrome was found in 3 – 4% of patients. As a result of pneumonia, patients develop ventilation and perfusion disorders, weakness of skeletal muscles. To recover patients after viral pneumonia, methods of pulmonary rehabilitation should be applied. This article represents the methods of pulmonary rehabilitation aimed to improve the blood circulation in the lungs, the ventilation-perfusion ratios, and to the restoration of the skeletal muscles.

CORONOVIRUS INFECTION COVID-19. MASKS (literature review)

2021 ◽  
Vol 7 (1) ◽  
pp. 24-32
Author(s):  
Semen Kireev ◽  
I. Popov ◽  
A. Ban'kovskiy ◽  
E. Litvinenko ◽  
E. Surova
Keyword(s):  
World Health Organization ◽  
Infectious Agent ◽  
International Committee ◽  
World Health ◽  
Vulnerable Communities ◽  
Regional Director ◽  
The World ◽  
Coronavirus Infection ◽  
Health Organization ◽  
The City

At the end of 2019, an outbreak of a new coronavirus infection occurred in the People's Re-public of China with an epicenter in the city of Wuhan (Hubei province). On February 11, 2020, the World Health Organization has assigned the official name of the infection caused by the new coronavirus - COVID-19 ("Coronavirus disease2019"). On February 11, 2020, the International Committee on Virus Taxonomy gave the official name to the infectious agent - SARS-CoV-2.Since the end of January 2020, cases of COVID-19 have begun to be registered in many coun-tries of the world, mainly associated with travel to the PRC. At the end of February 2020, the epidemiological situation with COVID-19 in South Korea, Iran and Italy sharply worsened, which subsequently led to a significant increase in the number of cases in other countries of the world associated with travel to these countries, incl. and in Russia. The World Health Organiza-tion announced the COVID-19 pandemic on 11 March 2020, and the pandemic's challenge to the world will remain so as long as people are not immune to it.The Regional Director of the World Health Organization Takeshi Kasai, on the basis of an epidemiological analysis, reports that the spread of coronavirus infection COVID-19 in July-August 2020 occurred mainly among people under 50 years old, and they often did not even know about it, because they had mild or no symptoms. In the future, these people then infect older people who are more difficult to tolerate COVID-19. And we need to redouble our efforts to prevent the spread of the virus in vulnerable communities.

scholarly journals Role of nutrients regulation in the immune system in preventing COVID-19 infection: A brief review

2021 ◽  
Vol 13 (2) ◽  
pp. 760-765
Author(s):  
Anamika Chauhan
Keyword(s):  
Immune System ◽  
Age Groups ◽  
World Health ◽  
The Novel ◽  
Beneficial Effects ◽  
Coronavirus Infection ◽  
The Common ◽  
Novel Coronavirus ◽  
Health Organization

This review aimed to focus on using foods to boost immunity against COVID-19 in all age groups. In human, coronavirus causes the common cold, severe acute respiratory syndrome (SARS), and a major threat to public health. The novel coronavirus was declared a pandemic by the World Health Organization due to its rapid infectivity. COVID-19 infection is most probably reported in people with low immunity response. The nutrients, which show beneficial effects on the immune system, are called immune nutrients and diet is called immune diet. A healthy diet can reduce the risk of infection of COVID-19 and can prevent disease. Nutritional food intake is also necessary for people with chronic illness, obese persons, diabetes, cardiovascular disease, cognitive dysfunction like anxiety and depression. All nutrients are essential for maintaining immunity and providing appropriate amounts of protein, fat, carbohydrate, vitamins, and minerals for the surveillance mode of keeping us from getting sick. The use of plenty of water, minerals such as micronutrients, zinc, copper, selenium, iron, magnesium, food rich in vitamins, and a good lifestyle can promote health and overwhelm this coronavirus infection.

scholarly journals Medical and social rehabilitation for new coronavirus infection (covid-19). temporal methodological recommendations of the Russian Federation and European countries (literature review)

2021 ◽  
Vol 23 (4) ◽  
pp. 47-52
Author(s):  
Elena Y. Lapina ◽  
Anatoly A. Yakushev
Keyword(s):  
Causative Agent ◽  
International Committee ◽  
World Health ◽  
Republic Of China ◽  
The World ◽  
The Status ◽  
Coronavirus Infection ◽  
The Russian Federation ◽  
The Moment ◽  
Health Organization

At the end of 2019, the Peoples Republic of China (PRC) faced an outbreak of a new coronavirus infection, the causative agent of which was given the name 2019-nCoV. Subsequently, the World Health Organization (WHO) on February 11, 2020 gave the official name of the infection COVID-19 (Coronavirus disease 2019). The International Committee for Taxonomy of Viruses has named the causative agent SARS-CoV-2. The virus quickly spread throughout the world and acquired the status of an epidemic. It was necessary to develop algorithms for rapid diagnosis, provision of specialized medical care, as well as rehabilitation and prevention of recurrence. At the moment, all data is accumulated in real time. And the information on rehabilitation and prevention of re-infection is completely minimal.

scholarly journals Invasive aspergillosis associated with COVID-19

2021 ◽  
Vol 31 (5) ◽  
pp. 671-676
Author(s):  
Nikolay V. Ovsyannikov ◽  
Olga A. Bilevich ◽  
Lyudmila A. Zenkova ◽  
Olga V. Vasilieva
Keyword(s):  
Invasive Aspergillosis ◽  
Fatal Outcome ◽  
Invasive Pulmonary Aspergillosis ◽  
World Health ◽  
Medical Community ◽  
The Novel ◽  
Pulmonary Aspergillosis ◽  
Coronavirus Infection ◽  
Novel Coronavirus ◽  
Health Organization

The novel coronavirus (COVID-19) pandemic announced by the World Health Organization in March 2020 has brought new tasks to the medical community that require immediate solutions. Recent studies have shown that invasive aspergillosis associated with coronavirus infection caused by COVID-19 often aggravates the course of the disease and leads to death. The article presents a clinical case of acute invasive aspergillosis in a COVID-19 patient with chronic somatic pathology but no risk factors for developing invasive pulmonary aspergillosis. The disease was progressing rapidly and led to a fatal outcome.Conclusion. In the case presented, invasive pulmonary aspergillosis was diagnosed with the help of histological examination of autopsy material.

scholarly journals A quick look at the latest developments in the COVID-19 pandemic

2020 ◽  
Vol 48 (9) ◽  
pp. 030006052094380 ◽  
Author(s):  
Ling Xue ◽  
Jiao Li ◽  
Lin Wei ◽  
Cuiqing Ma
Keyword(s):  
Theoretical Basis ◽  
International Committee ◽  
World Health ◽  
The Novel ◽  
Comprehensive Understanding ◽  
Isolation And Identification ◽  
The World ◽  
Emerging Virus ◽  
Novel Coronavirus ◽  
Health Organization

In December 2019, a new respiratory disease manifesting as viral pneumonia emerged in Wuhan, China. Isolation and identification of the virus showed that the pathogen causing this disease was a novel coronavirus. On January 12, 2020, the World Health Organization named the novel coronavirus causing the outbreak 2019 novel coronavirus (2019-nCoV). The disease caused by the virus was named coronavirus disease 2019 (COVID-19). Later, the Coronavirus Study Group of the International Committee on Taxonomy of Viruses formally named this virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus shows strong infectivity and high lethality, arousing widespread concern. As an emerging virus, a comprehensive understanding of SARS-CoV-2 is missing. To provide a reference and a theoretical basis for further study of SARS-CoV-2, recent advances in our understanding of the virus are summarized in this review.

scholarly journals Review on COVID-19: Rise of SARS-CoV-2 Pandemic Outbreak

2020 ◽  
Vol 3 (Special-1) ◽  
pp. 103-120 ◽  
Author(s):  
Vidhan Chand Bala ◽  
Punet Kumar
Keyword(s):  
World Health ◽  
Whole Genome ◽  
The Novel ◽  
The Family ◽  
The World ◽  
Coronavirus Infection ◽  
Genome Level ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Bat Coronavirus

Initially recognized of COVID-19 within the world in 2019, the World Health Organization situational report from May 22nd, 2020, globally, there is a complete of 5,204,508 confirmed cases, with 212 countries being affected by the novel coronavirus. 2019 novel coronavirus (SARS-CoV-2) is that the seventh member of the family of coronaviruses is enveloped viruses with a positive sense, single-stranded RNA genome. The SARS-CoV-2 may be a �-CoV of group 2B there is 70% comparability in genetic sequence to SARS-CoV. The source of the new coronavirus infection has been resolved as bats. With whole-genome sequences of SARS-CoV-2 is 96% comparatively at the whole-genome level to a bat coronavirus. Mechanisms of transmission are concluded to incorporate contact, droplet, and possibly airborne under certain circumstances supported ancient experiences associated with SARS-CoV outbreaks. Although antiretroviral therapy is being widely used everywhere the globe for such patents, effects at finding a SARS-CoV vaccine haven�t succeeded so far.

Melatonin as a potential therapeutic molecule against COVID-19 associated gastrointestinal complications: An unrevealed link

2020 ◽  
Vol 3 (3) ◽  
pp. 417-435
Author(s):  
Palash Kumar Pal ◽  
Aindrila Chattopadhyay ◽  
Debasish Bandyopadhyay
Keyword(s):  
Viral Infections ◽  
Gastrointestinal Symptoms ◽  
International Committee ◽  
World Health ◽  
Clinical Implications ◽  
The Novel ◽  
Gastrointestinal Complications ◽  
Specific Receptors ◽  
Novel Coronavirus ◽  
Health Organization

Outbreak of the novel coronavirus disease (COVID-19) was first reported in Wuhan, Hubei province of China, in early December 2019 which was later declared as a pandemic by World Health Organization (WHO) in March 2020. The International Committee on Taxonomy of Viruses has termed this novel coronavirus as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the report of WHO on 29th April, 2020, 3018681 confirmed cases along with 207973 deaths have been documented globally. COVID-19 was originally reported as a lethal lung disease with fever and cough as the most common symptoms; however, the increasing number of gastrointestinal symptoms, such as diarrhoea, vomiting and abdominal pain in patients have clearly suggested that gastrointestinal tract (GIT) may also serve as a potential route for SARS-CoV-2 infection. To identify the effective therapies on this pandemic is urgent. Keeping this in mind, we realize that melatonin is a potent antioxidant, anti-inflammatory and immunomodulatory molecule and it has been used in diverse diseases and pathophysiological conditions, including respiratory disease and viral infections. Importantly, melatonin specific receptors and its endogenously synthetic machinery are distributed throughout the mammalian gastrointestinal system. Therefore, the therapeutic potentiality of melatonin in SARS-CoV-2 associated digestive symptoms cannot be ignored. In this review, we focus on the clinical implications of melatonin on the digestive complications associated with SARS-CoV-2 infection. 

scholarly journals COVID-19 and ophthalmology: is conjunctival transmission possible?

2020 ◽  
Vol 1 (1) ◽  
pp. 18-21
Author(s):  
Alexander Surov ◽  
◽  
Ekaterina Lyuft ◽  
Irina Svinareva ◽  
◽  
...  
Keyword(s):  
World Health ◽  
Medical Community ◽  
Central Hospital ◽  
Republic Of China ◽  
First Case ◽  
The World ◽  
Scientific Papers ◽  
Coronavirus Infection ◽  
Health Organization ◽  
The City

At the end of 2019, an outbreak of a new coronavirus infection occurred in the people's Republic of China with an epicenter in the city of Wuhan (Hubei province). On February 11, 2020, the World Health Organization assigned the official name of the infection caused by the new coronavirus – COVID-19 (Coronavirus Disease 2019). As of May 2020, COVID-19 has been confirmed in nearly three and a half million people and has resulted in just over 230.000 deaths. In January 2020, the first case of death of an ophthalmologist from Wuhan Central hospital who was infected from a patient was recorded, which attracted the attention of the medical community around the world, especially in countries at the center of the pandemic. There are scientific papers showing the possibility of infection with the COVID-19 virus through the mucous membrane of the eye, which is relevant for doctors working in a pandemic, especially practicing ophthalmologists and General practitioners.

scholarly journals A novel coronavirus infection COVID-19 in practice of obstetrician-gynecologist: a review of current data and guidelines

2020 ◽  
Vol 14 (2) ◽  
pp. 148-158
Author(s):  
E. Yu. Iupatov ◽  
L. I. Maltseva ◽  
R. S. Zamaleeva ◽  
T. P. Zefirova ◽  
O. V. Chechulina ◽  
...  
Keyword(s):  
Severe Pneumonia ◽  
Current Data ◽  
World Health ◽  
Republic Of China ◽  
New Type ◽  
Immunological Suppression ◽  
Coronavirus Infection ◽  
American Society ◽  
Novel Coronavirus ◽  
Health Organization

In December 2019, a new type of coronavirus was identified in China, called SARS-CoV-2 (COVID-19) that quickly spread not only within the People’s Republic of China, but also far beyond its borders. On March 11, 2020, the World Health Organization announced that the infection caused by novel coronavirus SARS-CoV-2 became a pandemic. Prior to this, two global epidemics were caused by pathogenic coronaviruses: in 2002 – by SARS-CoV that caused severe acute respiratory syndrome (SARS), and in 2012 – by MERSCoV that resulted in the Middle East respiratory syndrome (MERS). All coronavirus infections in humans are characterized by damage of lower respiratory tract with development of severe pneumonia and respiratory distress syndrome. According to reports, males become sick more often than females. It is known that due to developing immunological suppression pregnant women are at higher risk of contracting infectious diseases. However, the clinical course of SARS-CoV-2 infection during pregnancy, its effect on outcome of gestation, and the likelihood of vertical transmission to the fetus still remain unanswered. In this review, we present data on cases of SARS-CoV-2 disease during pregnancy published globally, its effect on outcome of gestation, as well as data on potential routes of infection for fetus and neonates. In addition, we also provide currently available clinical recommendations released by the Royal Society of Obstetricians and Gynecologists (UK), the American Society of Obstetricians and Gynecologists (USA), and the National Institute for Reproductive Health Research (India) on the management of pregnant patients infected with SARS-CoV-2.

scholarly journals Potential of CRISPR/Cas13 System in Treatment and Diagnosis of COVID-19

2021 ◽  
Author(s):  
Amir Khodavirdipour ◽  
Motahareh Piri ◽  
Sarvin Jabbari ◽  
Mohammad Khalaj-kondori
Keyword(s):  
Diagnostic Tool ◽  
Human Kidney ◽  
World Health ◽  
Rapid Review ◽  
The Novel ◽  
Rapid Action ◽  
Antiparasitic Drug ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Treatment And Diagnosis

AbstractThe novel coronavirus disease 2019 (COVID-19) belongs to coronaviridae families, like sarbecovirus (SARS), and causes pyrexia, pertussis, and acute respiratory distress syndrome (ARDS) in major. Started from Wuhan, China now forced the World Health Organization (WHO) to call it a pandemic. These dreadful figures elevate the need for rapid action for a rapid diagnostic tool, an efficacious therapy, or vaccine for such widespread disease. Here we reviewed all the latest research and trials including conventional antiviral medicines that have a narrow and finite effect on COVID-19. Recently, some advances have been made by a nucleotide/nucleoside analogues (NUC) inhibitor (remdesivir), ivermectin (antiparasitic drug), and convalescent plasma, the later one has more recently been approved by the Food and Drug Administration (FDA). In addition, a clinical-grade soluble human angiotensin-converting enzyme (ACE2), named hrsACE2, was able to inhibit the infection of human blood vessel organoids, as well as the human kidney organoids, by the virus. As of now, innovative therapeutics based on the CRISPR/Cas13d might overcome the challenge of COVID-19 either as a treatment option or precise and rapid diagnostic tool due to its rapid and precise nature. In this updated comprehensive rapid review, we try to cover all recent findings in terms of genomics, diagnosis, prevention, and treatment.

Sign in / Sign up

Export Citation Format

Share Document